Relmada Therapeutics (RLMD) EBIT (2012 - 2026)
Relmada Therapeutics' EBIT was -$15.01 million in Q2 2026, compared with -$10.22 million a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) EBIT (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Relmada Therapeutics' EBIT was -$65.13 million through Jun 30, 2026; for FY2025, it came in at -$59.1 million.
- In earlier years, EBIT was -$83.89 million in FY2024, -$103.7 million in FY2023, -$161.25 million in FY2022 and -$125.7 million in FY2021.
- Quarterly EBIT has moved between -$45.51 million (Q2 2022) and -$10.22 million (Q2 2025) over five years.
- Per Business Quant data, RLMD's EBIT in the three quarters before Q2 2026 was -$19.46 million (Q1 2026), -$20.33 million (Q4 2025) and -$10.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Relmada Therapeutics | 361.85 Mn | -196.74 Mn | - | -15.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.01 Mn |
| Mar 31, 2026 | -19.46 Mn |
| Dec 31, 2025 | -20.33 Mn |
| Sep 30, 2025 | -10.33 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -18.22 Mn |
| Dec 31, 2024 | -19.08 Mn |
| Sep 30, 2024 | -23.01 Mn |
| Jun 30, 2024 | -18.82 Mn |
| Mar 31, 2024 | -22.99 Mn |
| Dec 31, 2023 | -26.83 Mn |
| Sep 30, 2023 | -22.69 Mn |
| Jun 30, 2023 | -26.03 Mn |
| Mar 31, 2023 | -28.15 Mn |
| Dec 31, 2022 | -38.70 Mn |
| Sep 30, 2022 | -38.74 Mn |
| Jun 30, 2022 | -45.51 Mn |
| Mar 31, 2022 | -38.30 Mn |
| Dec 31, 2021 | -34.18 Mn |
| Sep 30, 2021 | -42.65 Mn |
API Access
Relmada Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();